NewsRx

Search our medical news database

Adverse Drug Effects

Potentially Fatal Heart Disorder Linked To More Than 50 Common Prescription Medications

Published in Hepatitis Weekly, April 23rd, 2001

According to recently released survey results, many doctors may not have enough information about Long QT Syndrome, a potentially fatal disorder of the heart's electrical system, to protect patients from developing the condition.

Although doctors say they are familiar with Long QT, the survey suggests they do not fully understand its symptoms or who is at risk.

Long QT is associated with heart rhythm disorders and is becoming an increasingly urgent problem as widely prescribed drugs, such as the heartburn agent Propulsid and the antihistamine Seldane, are removed from the market. Other QT prolonging drugs, such as the antipsychotic Mellaril, remain...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook